342. National Institutes of Health. NIH awards $23 million to establish centers of excellence to study telehealth for cancer care. Accessed: July 5, 2023. Available from: https://www.nih.gov/news-events/news-releases/nihawards-23-million-establish-centers-excellence-studytelehealth-cancer-care. 343. Patel KB, et al. (2023) J Natl Compr Canc Netw, 21: 496. 344. Patel KB, et al. (2023) JAMA Netw Open, 6: e2250211. 345. Waseem N, et al. (2022) JAMA Netw Open, 5: e2220543. 346. Hamdy FC, et al. (2023) N Engl J Med, 388: 1547. 347. Lawrence W. History of Surgical Oncology. In: Norton JA, Barie PS, Bollinger RR, Chang AE, Lowry SF, Mulvihill SJ, et al., editors. Surgery. New York, NY: Springer New York; 2008. p 1889. 348. Gianfaldoni S, et al. (2017) Open Access Maced J Med Sci, 5: 521. 349. DeVita VT, Jr., et al. (2008) Cancer Res, 68: 8643. 350. Dobashi Y, et al. (2012) Chemotherapy, 1: 2. 351. Zhang Y, et al. (2020) Cell Mol Immunol, 17: 807. 352. Modi S, et al. (2022) N Engl J Med, 387: 9. 353. Gupta A, et al. (2023) Sci Rep, 13: 8190. 354. Kirtane K, et al. (2023) Cancer Med, 12.13687. 355. Liu X, et al. (2023) JAMA Netw Open, 6: e2251524. 356. Hougen HY, et al. (2023) JCO Oncol Pract: OP2300040. 357. Logan CD, et al. (2023) J Surg Res, 283: 1053. 358. Bikomeye JC, et al. (2023) J Natl Cancer Inst, 115: 652. 359. Burotto M, et al. (2019) Semin Oncol, 46: 83. 360. Gustafsson UO, et al. (2019) World J Surg, 43: 659. 361. Santa Mina D, et al. (2017) PM R, 9: S305. 362. Chakravarthy VB, et al. (2022) Cancer, 128: 4109. 363. Molenaar CJL, et al. (2023) JAMA Surg, 158: 572. 364. Altorki N, et al. (2023) N Engl J Med, 388: 489. 365. Topal H, et al. (2022) JAMA Netw Open, 5: e2248147. 366. Son SY, et al. (2022) JAMA Surg, 157: 879. 367. Di Benedetto F, et al. (2023) JAMA Surg, 158: 46. 368. Kuerer HM, et al. (2022) Lancet Oncol, 23: 1517. 369. Bartels SAL, et al. (2023) J Clin Oncol, 41: 2159. 370. Uramoto H, et al. (2014) Transl Lung Cancer Res, 3: 242. 371. Migliore M, et al. (2018) Ann Transl Med, 6: 90. 372. Huang C, et al. (2019) J Cancer, 10: 6888. 373. Sarkaria IS, et al. (2023) J Thorac Cardiovasc Surg. 374. Maroongroge S, et al. (2022) Int J Radiat Oncol Biol Phys, 112: 600. 375. Wang K, et al. (2021) CA Cancer J Clin, 71: 437. 376. Kunkler IH, et al. (2023) N Engl J Med, 388: 585. 377. Schrag D, et al. (2023) N Engl J Med, 389: 322. 378. Santoro M, et al. (2022) Applied Sciences, 12: 3223. 379. Ng J, et al. (2023) Front Oncol, 13: 1117874. 380. The ASCO Post Staff. FDA Approves Flotufolastat Fluorine-18 Injection, First Radiohybrid PSMA-Targeted PET Imaging Agent for Prostate Cancer. Accessed: July 5, 2023. Available from: https://ascopost.com/news/may2023/fda-approves-flotufolastat-fluorine-18-injectionfirst-radiohybrid-psma-targeted-pet-imaging-agent-forprostate-cancer/. 381. East P, et al. (2022) Nat Commun, 13: 5632. 382. Rais R, et al. (2022) Sci Adv, 8: eabq5925. 383. Kotani D, et al. (2023) Nat Med, 29: 127. 384. Janne PA, et al. (2022) N Engl J Med, 387: 120. 385. Kotecha R, et al. (2022) N Engl J Med, 387: 1238. 386. Li BT, et al. (2022) N Engl J Med, 386: 241. 387. Riudavets M, et al. (2021) ESMO Open, 6: 100260. 388. National Cancer Institute. Enhertu Approved for Lung Cancer. Accessed: July 5, 2023. Available from: https:// www.cancer.gov/news-events/cancer-currents-blog/2022/ fda-lung-cancer-enhertu-her2?cid=eb_govdel. 389. Sengupta R, et al. (2020) Clin Cancer Res, 26: 5055. 390. Goulart BHL, et al. (2021) Clin Lung Cancer, 22: e723. 391. Lemmon CA, et al. (2023) JCO Precis Oncol, 7: e2200294. 392. Osazuwa-Peters OL, et al. (2023) Clin Lung Cancer, 24: 305. 393. Sadik H, et al. (2022) JCO Precis Oncol, 6: e2200246. 394. Duke ES, et al. (2023) Clin Cancer Res: OF1. 395. Subbiah V, et al. (2022) Lancet Oncol, 23: 1261. 396. Dilawari A, et al. (2023) Clin Cancer Res, OF1. 397. Matulonis UA, et al. (2023) J Clin Oncol, 41: 2436. 398. Angelergues A, et al. (2023) Journal of Clinical Oncology, 41: LBA5507. 399. Bidard FC, et al. (2022) J Clin Oncol, 40: 3246. 400. Goyal L, et al. (2023) N Engl J Med, 388: 228. 401. Sengupta R, et al. (2021) Clin Cancer Res, 27: 5757. 402. Dankner M, et al. (2018) Oncogene, 37: 3183. 403. Flaherty KT, et al. (2012) N Engl J Med, 367: 1694. References AACR Cancer Progress Report 2023 175
RkJQdWJsaXNoZXIy NTkzMzk=